Supporting Treatment Access and Recovery Through Linkage and Support

Summary

This 3-year Hybrid Type 1 study will randomize 208 people with co-occurring substance use and mental health disorders (COD) referred from the Worcester Hub. This study seeks to evaluate the effectiveness of MISSION, a multi-component team approach, versus linkage with a Peer Specialist on improving outcomes among individuals with CODs. We expect that individuals receiving MISSION versus linkage only will show greater improvement in treatment engagement, substance use, and mental health outcomes. This study will also concurrently conduct a process evaluation to inform sustainability and future implementation of such interventions.

Conditions

• Mental Health Disorders
• Substance Use Disorders

Interventions

BEHAVIORAL

Full MISSION

MISSION is a time-limited, cross disciplinary, team-based wraparound approach that provides 6 months of psychosocial treatment combined with assertive outreach, empowering clients to access and engage in care and community services to promote recovery. The MISSION treatment curriculum integrates 3 evidence-based practices: 1) Critical Time Intervention (CTI), a time-limited form of assertive community treatment; 2) Dual Recovery Therapy (DRT), which is integrated mental health and substance use group therapy; and 3) Peer Support (PS), offering support for people in recovery by people in recovery.

BEHAVIORAL

Linkage Only Delivered by a Peer Specialist

Linkage only is provided via Peer Specialists whom have lived experiences similar to that of our participants. Linkage only includes informal treatment planning and linkages and supports to needed community services.

Sponsors & Collaborators

• Centers for Disease Control and Prevention

  collaborator FED

• University of Massachusetts, Lowell

  collaborator OTHER

• University of Massachusetts, Amherst

  collaborator OTHER

• University of Massachusetts, Worcester

  lead OTHER

Principal Investigators

• David Smelson, PsyD · University of Massachusetts, Worcester

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-05-24

Primary Completion

2026-09-30

Completion

2026-09-30

Countries

• United States

Study Locations